Enhancement of coronary vasodilating action of ATP and adenosine by lidoflazine.
D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000619:Aminohydrolases; D000818:Animals; D001783:Blood Flow Velocity; D003331:Coronary Vessels; D004176:Dipyridamole / Q000494:pharmacology; D004285:Dogs; D004357:Drug Synergism; D009705:Nucleosides / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology
D009705:Nucleosides; D010879:Piperazines; D014665:Vasodilator Agents; D004176:Dipyridamole; D000255:Adenosine Triphosphate; D000619:Aminohydrolases